Materializing the future of vaccines and immunotherapy

Nature Reviews Materials

Volumn 1, Issue 1, 2016, Pages

  Irvine, Darrell J ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85016014866     PISSN: None     EISSN: 20588437     Source Type: Journal    
DOI: 10.1038/natrevmats.2015.8     Document Type: Note

References (5)

1. Mellman, I., Coukos, G. & Dranoff, G. Cancer immunotherapy comes of age. Nature 480, 480-489 (2011).
2. Cheung, A. S. & Mooney, D. J. Engineering materials for cancer immunotherapy. Nano Today http:org/10.1016/j. nantod.2015.06.007 (2015).
3. Mascola, J. R. & Haynes, B. F. HIV-1 neutralizing antibodies: understanding nature's pathways. Immunol. Rev. 254, 225-244 (2013).
4. Boesch, A. W., Alter, G. & Ackerman, M. E. Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life. Curr. Opin. HIV AIDS 10, 160-169 (2015).
5. Kwong, G. A. et al. Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. Nat. Biotechnol. 31, 63-70 (2013).